Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Brentuximab Vedotin Monotherapy in DLBCL Patients with Undetectable CD30: Preliminary Results from a Phase 2 Study Bartlett, N. L., Smith, M. R., Advani, R., Feldman, T., Savage, K. J., Palanca-Wessels, M., Siddiqi, T. AMER SOC HEMATOLOGY. 2014
View details for Web of Science ID 000349233800109